Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) entered a Purchase and Sale deal to acquire a research and development (R&D) facility. The facility in question measures 48,000 square foot and will play a crucial role in helping the company develop a viral vaccine expected to stage a strong fight against COVID-19. Details […]